Analyze Diet

Pulmonary vascular pressures of strenuously exercising Thoroughbreds during intravenous infusion of nitroglycerin.

Abstract: To determine whether intravenous infusion of nitroglycerin would modify pulmonary arterial, capillary, or venous hypertension in strenuously exercising Thoroughbreds. Methods: 5 healthy Thoroughbred horses. Methods: Right atrial, right ventricular, and pulmonary vascular pressures were measured. Each horse was used in a control treatment (not medicated) and a nitroglycerin infusion (20 microg/kg of body weight/min) at rest and during exercise on a treadmill. Sequence of treatments was randomized for each horse, and treatments were separated by a 7-day interval. Galloping at 14.2 m/s on a 5% uphill grade elicited maximal heart rate (mean +/- SEM, 212 +/- 2 beats/min) and could not be sustained for > 90 seconds. Nitroglycerin dosage was selected, because maximal pulmonary and systemic hemodynamic effects of i.v. nitroglycerin were elicited at 5 microg/kg/min and increasing the dosage to 20 microg/kg/min did not cause adverse effects. Results: In the control treatment, exercise performed at maximal heart rate resulted in a significant increase in right atrial as well as pulmonary arterial, capillary, and wedge pressures. Nitroglycerin infusion in standing horses significantly decreased right atrial and pulmonary vascular pressures, whereas heart rate increased. Exercise in nitroglycerin-infused horses also resulted in a significant increase in right atrial as well as pulmonary arterial, capillary, and wedge pressures, and these values were not significantly different from data for the control treatment. All horses experienced exercise-induced pulmonary hemorrhage for both treatments. Conclusions: I.v. administration of nitroglycerin does not modify exercise-induced pulmonary hypertension and is unlikely to affect the incidence or severity of exercise-induced pulmonary hemorrhage in Thoroughbreds.
Publication Date: 1999-11-24 PubMed ID: 10566823
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article investigates whether intravenous nitroglycerin could affect pulmonary arterial, capillary, or venous hypertension in strenuously working Thoroughbred horses. The conclusion was that nitroglycerin administration did not change exercise-induced hypertension and is unlikely to impact the degree or frequency of exercise-induced pulmonary hemorrhage in these horses.

Methods

  • Five healthy Thoroughbred horses were analyzed in this study. The sequence of treatments was randomized for each horse and they were administered a week apart.
  • Both resting and exercising state of the horses were examined. Exercise included running on a treadmill, with galloping at a speed of 14.2 m/s on a 5% uphill grade, which could not be sustained for more than 90 seconds.
  • The vital observations included measuring right atrial, right ventricular, and pulmonary vascular pressures in each horse. These parameters were recorded during a control treatment (where the horses were not medicated) and a nitroglycerin infused state.
  • The dosage of nitroglycerin was carefully chosen. Maximal pulmonary and systemic hemodynamic effects of intravenous nitroglycerin were seen at 5 microg/kg/min, so a quadruple dose (20 microg/kg/min) was used, as it did not cause any adverse effects.

Results

  • During the control treatment, exercise that pushed the horses’ heart rates to maximum led to a significant increase in right atrial and pulmonary arterial, capillary, and wedge pressures.
  • Infusion of nitroglycerin in a standing horse significantly reduced right atrial and pulmonary vascular pressures. However, an increase in heart rate was observed.
  • For the horses that were administered nitroglycerin and made to exercise, similar increases in right atrial and pulmonary arterial, capillary, and wedge pressures were observed. These parameter values were not significantly different from the control treatment data.
  • In both the treatments, all horses showed signs of exercise-induced pulmonary hemorrhage.

Conclusions

  • The findings conclude that intravenously administered nitroglycerin does not affect exercise-induced pulmonary hypertension.
  • Furthermore, it is unlikely to have any impact on the incidence or severity of exercise-induced pulmonary hemorrhage in Thoroughbreds.

Cite This Article

APA
Manohar M, Goetz TE. (1999). Pulmonary vascular pressures of strenuously exercising Thoroughbreds during intravenous infusion of nitroglycerin. Am J Vet Res, 60(11), 1436-1440.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 60
Issue: 11
Pages: 1436-1440

Researcher Affiliations

Manohar, M
  • Department of Veterinary Biosciences, College of Veterinary Medicine, University of Illinois, Urbana 61801, USA.
Goetz, T E

    MeSH Terms

    • Animals
    • Blood Pressure / drug effects
    • Blood Pressure / physiology
    • Capillaries / drug effects
    • Capillaries / physiology
    • Dose-Response Relationship, Drug
    • Horses / physiology
    • Infusions, Intravenous
    • Male
    • Nitroglycerin / administration & dosage
    • Nitroglycerin / pharmacology
    • Physical Conditioning, Animal / physiology
    • Physical Exertion / drug effects
    • Physical Exertion / physiology
    • Pulmonary Artery / drug effects
    • Pulmonary Artery / physiology
    • Pulmonary Circulation / drug effects
    • Pulmonary Circulation / physiology
    • Random Allocation
    • Rest

    Citations

    This article has been cited 1 times.
    1. Poole DC, Erickson HH. Exercise-induced pulmonary hemorrhage: where are we now?. Vet Med (Auckl) 2016;7:133-148.
      doi: 10.2147/VMRR.S120421pubmed: 30050846google scholar: lookup